Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.
References:
https://pubmed.ncbi.nlm.nih.gov/41632432/
https://pubmed.ncbi.nlm.nih.gov/42198294/
https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/